sBioMed® is a biomedical research firm headquartered in Utah. With decades and multi millions invested in research and development, sBioMed® has achieved monumental scientific breakthroughs with the advent of STERIPLEX infection control technology. sBioMed® technologies are protected by significant EPA registrations and sixty-one U.S. and global patents.
The sBioMed® mission is to save lives and improve lives through groundbreaking infection control products that greatly improve quality of care. This mission combines continued research, committed partners and satisfied customers. The result of over 20 years of commitment and vision, STERIPLEX technology provides a high level of decontamination. Health care providers from around the world can now be armed with new tools in defending their patients from the world’s most dangerous microorganisms. Our teams of research scientists, medical professionals, educators and marketing experts continually strive to improve patient care environments and reduce incidence of health care acquired infections.
sBioMed® is committed to consistently meet or exceed customer expectations related to product efficacy, cost, quality and timeliness through developments and commercialization of superior products based on the STERIPLEX platform, reducing cost of quality (COQ), compliance to ISO 9000 and on-time delivery to customers.